Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500105071Phase 4Not yet recruiting
Phase 4, randomised trial of norepinephrine in Hypothermia (2 arms), sponsored by Xuancheng People's Hospital. Primary endpoint: Intraoperative core temperature. Planned start Jun 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500105071.